Viracta Therapeutics PT Lowered to 4.00 - Defense World
| VIRXDelisted Stock | USD 0.03 0 7.38% |
Slightly above 62% of Viracta Therapeutics' investor base is looking to short. The analysis of overall sentiment of trading Viracta Therapeutics pink sheet suggests that many investors are alarmed at this time. Viracta Therapeutics' investing sentiment can be driven by a variety of factors including economic data, Viracta Therapeutics' earnings reports, geopolitical events, and overall market trends.
Viracta |
Viracta Therapeutics PT Lowered to 4.00 Defense World
Read at news.google.com
 |
Viracta Therapeutics Fundamental Analysis
We analyze Viracta Therapeutics' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Viracta Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Viracta Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Beta
Beta Comparative Analysis
Viracta Therapeutics is currently under evaluation in beta category among its peers. Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
Viracta Therapeutics Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Viracta Therapeutics pink sheet to make a market-neutral strategy. Peer analysis of Viracta Therapeutics could also be used in its relative valuation, which is a method of valuing Viracta Therapeutics by comparing valuation metrics with similar companies.
Peers
Viracta Therapeutics Related Equities
| GLUE | Monte Rosa | 9.61 | ||||
| LPTX | Leap Therapeutics | 5.88 | ||||
| BCYC | Bicycle Therapeutics | 5.14 | ||||
| STOK | Stoke Therapeutics | 4.50 | ||||
| CABA | Cabaletta Bio | 4.31 | ||||
| BMEA | Biomea Fusion | 2.94 | ||||
| XFOR | X4 Pharmaceuticals | 1.54 | ||||
| MREO | Mereo BioPharma | 1.26 | ||||
| TARA | Protara Therapeutics | 0.60 | ||||
| TRVI | Trevi Therapeutics | 0.30 | ||||
| IGMS | IGM Biosciences | 0.88 | ||||
| TERN | Terns Pharmaceuticals | 0.99 | ||||
| TNYA | Tenaya Therapeutics | 2.09 | ||||
| RLYB | Rallybio Corp | 2.33 | ||||
| EYPT | Eyepoint Pharmaceuticals | 2.40 | ||||
| ALXO | Alx Oncology | 4.12 | ||||
| INZY | Inozyme Pharma | 6.77 |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Other Consideration for investing in Viracta Pink Sheet
If you are still planning to invest in Viracta Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Viracta Therapeutics' history and understand the potential risks before investing.
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |